Mangoceuticals Competitors

Stocks . USA . 
Stock . Mangoceuticals Common Stock
MGRX Stock   0.54  0.02  3.85%   
Mangoceuticals Common competes with Thrivent High, Morningstar Unconstrained, Via Renewables, T Rowe, and Sitka Gold; as well as few others. The company conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. Analyzing Mangoceuticals Common competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Mangoceuticals Common to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Mangoceuticals Common Correlation with its peers.

Mangoceuticals Common vs Sycamore Entmt Correlation

Very weak diversification

The correlation between Mangoceuticals Common Stock and SEGI is 0.58 (i.e., Very weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Mangoceuticals Common Stock and SEGI in the same portfolio, assuming nothing else is changed.

Moving together with Mangoceuticals Stock

  0.83IL3 Integra LifeSciencesPairCorr
  0.61EW Edwards Lifesciences CorpPairCorr

Moving against Mangoceuticals Stock

  0.75DXCM DexCom IncPairCorr
  0.74HYB HOYAPairCorr
Return On Tangible Assets is likely to rise to -68.98 in 2026. Return On Capital Employed is likely to drop to -0.69 in 2026. At this time, Mangoceuticals Common's Total Assets are fairly stable compared to the past year. Net Tangible Assets is likely to rise to about 741.4 K in 2026, whereas Total Current Assets are likely to drop slightly above 82.6 K in 2026.
Specify up to 10 symbols:
Hype
Prediction
LowEstimatedHigh
0.020.4311.57
Details
Intrinsic
Valuation
LowRealHigh
0.030.5211.66
Details
Naive
Forecast
LowNextHigh
0.010.6611.81
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.540.540.54
Details

Mangoceuticals Common Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Mangoceuticals Common and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Mangoceuticals and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Mangoceuticals Common does not affect the price movement of the other competitor.

High positive correlations

OSHDF
+ 1.0
ONCSQ
RRTLX
+ 0.96
MSTSX
RRTLX
+ 0.95
VIASP
VIASP
+ 0.91
MSTSX
RWAYL
+ 0.86
RRTLX
RRTLX
+ 0.85
LBHIX
  

High negative correlations

SEGI
- 0.67
VIASP
SEGI
- 0.62
RRTLX
SEGI
- 0.6
MSTSX
SEGI
- 0.59
RWAYL
SEGI
- 0.48
LBHIX
SITKF
- 0.32
VIASP

Risk-Adjusted Indicators

There is a big difference between Mangoceuticals Stock performing well and Mangoceuticals Common Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Mangoceuticals Common's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
ONCSQ  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
 0.00 
 0.00 
LBHIX  0.12  0.04 (0.35) 0.46  0.00 
(0.22)
 0.24 
(0.12)
 2.15 
MSTSX  0.62  0.28  0.29  8.99  0.00 
(0.77)
 1.45 
(0.88)
 12.34 
VIASP  0.28  0.05 (0.09) 10.66  0.17 
(0.33)
 0.64 
(0.59)
 1.72 
RRTLX  0.25  0.07  0.06  0.31  0.00 
(0.34)
 0.57 
(0.40)
 3.30 
WQTM  1.68  0.07  0.05  0.12  1.88 
(1.73)
 3.48 
(3.22)
 9.00 
OSHDF  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
 0.00 
 0.00 
SITKF  2.67  0.20  0.06  0.28  2.79 
(3.55)
 7.81 
(5.71)
 16.83 
RWAYL  0.12  0.01 (0.40) 0.43  0.00 
(0.15)
 0.24 
(0.20)
 0.88 
SEGI  11.09  1.16  0.05  0.64  11.35 
(29.49)
 33.33 
(25.00)
 58.33 

Mangoceuticals Common Competitive Analysis

The better you understand Mangoceuticals Common competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Mangoceuticals Common's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Mangoceuticals Common's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
MGRX ONCSQ LBHIX MSTSX VIASP RRTLX WQTM OSHDF SITKF RWAYL
 3.85 
 0.54 
Mangoceuticals
 0.00 
 0.0001 
OncoSec
 0.17 
 17.17 
Thrivent
 0.53 
 11.47 
Morningstar
 0.47 
 25.73 
Via
 0.08 
 13.06 
RRTLX
 1.81 
 27.10 
WisdomTree
 0.00 
 0.04 
Oshidori
 2.53 
 0.81 
Sitka
 0.04 
 25.11 
MSCI
Market Volatility
(90 Days Market Risk)
Out of control
Very steady
Very steady
Not too volatile
Very steady
Very steady
Very steady
Very steady
Extremely Dangerous
Very steady
Market Performance
(90 Days Performance)
Weakest
Weakest
Good
Good
Good
Solid
Soft
Weakest
Mild
Good
Odds of Financial Distress
(Probability Of Bankruptcy)
Low
Unknown
Low
Low
Fair
Low
Fair
High
Moderate
Low
Current Valuation
(Equity Enterprise Value)
Over Valued
Over Valued
Over Valued
Fairly Valued
Under Valued
Fairly Valued
Fairly Valued
Over Valued
Over Valued
Over Valued
Buy or Sell Advice
(Average Analysts Consensus)
Strong Sell
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Strong Sell
Trade Advice
(90 Days Macroaxis Advice)
Strong Sell
Strong Sell
Strong Sell
Hold
Strong Buy
Sell
Hold
Strong Sell
Strong Sell
Strong Sell
Current Ratio
N/A
N/A
N/A
N/A
3.49
N/A
N/A
N/A
4.24
N/A
Net Asset
15.37 M
N/A
797.1 M
116.1 M
355.28 M
1.46 B
N/A
6.31 B
13.41 M
N/A
EBITDA
(7.96 M)
N/A
N/A
N/A
33.09 M
N/A
N/A
(3.49 B)
(1.57 M)
N/A
Operating Margin
-89.14
N/A
N/A
N/A
-0.14
N/A
N/A
1.04
N/A
N/A
Five Year Return
N/A
N/A
4.12
9.1
8.97
0.0406
N/A
N/A
N/A
N/A
One Year Return
N/A
N/A
7.75
15.47
N/A
0.067
N/A
N/A
N/A
N/A
Beta
2.72
N/A
N/A
N/A
1.16
N/A
N/A
0.67
1.45
N/A
Number Of Employees
3
N/A
1
1
169
1
N/A
31
1
N/A
Three Year Return
N/A
N/A
8.79
13.43
N/A
0.0491
N/A
N/A
N/A
N/A
Cash Flow From Operations
(4.86 M)
N/A
N/A
N/A
12.7 M
N/A
N/A
499.26 M
(1.27 M)
N/A
Total Debt
214.96 K
N/A
N/A
N/A
135 M
N/A
N/A
N/A
40 K
N/A
Bond Positions Weight
N/A
N/A
92.23
22.72
N/A
14.43
N/A
N/A
N/A
N/A
Holdings Turnover
N/A
N/A
N/A
269.0
N/A
N/A
N/A
N/A
N/A
N/A
Return On Asset
-0.74
N/A
N/A
N/A
-0.11
N/A
N/A
-0.46
-0.033
N/A
Current Liabilities
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Short Ratio
1.14
N/A
N/A
N/A
0.7
N/A
N/A
N/A
N/A
N/A
Debt To Equity
N/A
N/A
N/A
N/A
0.69
N/A
N/A
N/A
0.002
N/A
Shares Owned By Institutions
16.48
N/A
N/A
N/A
N/A
N/A
N/A
0.84
10.92
N/A
Market Capitalization
8.71 M
N/A
N/A
50.36 M
N/A
N/A
N/A
233.49 M
12.62 M
N/A
Price To Earning
N/A
N/A
35.48
N/A
26.83
18.25
N/A
N/A
N/A
N/A
Price To Sales
18.66
N/A
1.23
N/A
N/A
1.57
N/A
N/A
N/A
N/A
Net Income
(8.71 M)
N/A
N/A
N/A
5.2 M
N/A
N/A
(3.15 B)
(1.28 M)
N/A
Shares Owned By Insiders
11.04
N/A
N/A
N/A
N/A
N/A
N/A
30.28
5.97
N/A
Revenue
615.87 K
N/A
N/A
N/A
393.49 M
N/A
N/A
(3.1 B)
N/A
N/A
Year To Date Return
N/A
N/A
1.0
3.92
N/A
-0.0211
N/A
N/A
N/A
N/A
Working Capital
(1.35 M)
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Profit Margin
N/A
N/A
N/A
N/A
0.0094
N/A
N/A
N/A
N/A
N/A
Current Valuation
8.29 M
N/A
N/A
N/A
535.95 M
N/A
N/A
103.84 M
8.05 M
N/A
Price To Book
0.55
N/A
1.58
N/A
N/A
2.13
N/A
0.005
1.1
N/A
Retained Earnings
(20.81 M)
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Current Asset
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash Position Weight
N/A
N/A
6.56
14.28
N/A
7.22
N/A
N/A
N/A
N/A
Equity Positions Weight
N/A
N/A
0.07
61.63
N/A
38.52
N/A
N/A
N/A
N/A
Shares Outstanding
16.29 M
N/A
N/A
N/A
N/A
N/A
N/A
6.11 B
159.12 M
N/A
Annual Yield
N/A
N/A
0.0619
0.0218
0.0972
0.0283
N/A
N/A
N/A
N/A
Return On Equity
-1.36
N/A
N/A
N/A
0.017
N/A
N/A
-0.5
-0.0611
N/A
Z Score
N/A
N/A
N/A
N/A
1.0
N/A
N/A
N/A
N/A
N/A
Number Of Shares Shorted
430.54 K
N/A
N/A
N/A
4.29 K
N/A
N/A
N/A
N/A
2.19 K
Book Value Per Share
1.13
N/A
N/A
N/A
3.66
N/A
N/A
0.89
0.1
N/A
Minimum Initial Investment
N/A
N/A
2 K
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Asset
15.37 M
N/A
491.38 M
215.11 M
355.28 M
1.03 B
N/A
6.31 B
13.41 M
N/A
Last Dividend Paid
N/A
N/A
0.02
N/A
0.73
0.14
N/A
N/A
N/A
N/A
Target Price
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Earnings Per Share
-2.72
N/A
N/A
N/A
1.17
N/A
N/A
N/A
-0.01
N/A
Ten Year Return
N/A
N/A
6.0
N/A
N/A
5.76
N/A
N/A
N/A
N/A
Cash And Equivalents
N/A
N/A
N/A
N/A
51.31 M
N/A
N/A
N/A
5.77 M
N/A
Cash Per Share
N/A
N/A
N/A
N/A
3.23
N/A
N/A
N/A
0.04
N/A
Gross Profit
283.01 K
N/A
N/A
N/A
74.67 M
N/A
N/A
(4.09 B)
N/A
N/A
Day Typical Price
0.53
1.0E-4
17.17
11.47
25.68
13.06
26.96
0.036
0.81
25.15
Accumulation Distribution
0.0909
N/A
N/A
N/A
9.32
N/A
368.58
N/A
16887.22
20.02
Market Facilitation Index
0.05
N/A
N/A
N/A
1.0E-4
N/A
0.0
N/A
N/A
1.0E-4
Daily Balance Of Power
0.4
0.0
0
9.2 T
0.75
0
(1.11)
0.0
0.6667
0.0455
Period Momentum Indicator
0.02
N/A
(0.03)
0.06
0.12
(0.01)
(0.50)
N/A
0.02
0.01
Rate Of Daily Change
1.04
1.0
1.0
1.01
1.0
1.0
0.98
1.0
1.03
1.0
Day Median Price
0.53
1.0E-4
17.17
11.47
25.66
13.06
26.9
0.036
0.82
25.17
Price Action Indicator
0.025
N/A
(0.01)
0.03
0.13
(0.01)
(0.04)
N/A
0.005
(0.06)
Relative Strength Index
0.0478
N/A
33.85
94.4
57.57
95.26
64.52
N/A
57.72
24.42
Coefficient Of Variation
(2,254)
N/A
495.45
491.38
601.22
382.36
1089.77
N/A
1268.19
564.07
Mean Deviation
6.83
N/A
0.1245
0.6182
0.2839
0.2535
1.68
N/A
2.67
0.1172
Jensen Alpha
(0.60)
N/A
0.0358
0.2832
0.0497
0.0728
0.0655
N/A
0.1954
0.0143
Total Risk Alpha
(1.63)
N/A
0.0158
0.1341
0.0124
0.0548
(0.04)
N/A
(0.10)
0.0013
Sortino Ratio
N/A
N/A
(0.35)
0.2891
(0.09)
0.0555
0.0508
N/A
0.0567
(0.40)
Downside Variance
N/A
N/A
0.0109
0.5071
0.1204
0.1043
4.15
N/A
11.77
0.0248
Standard Deviation
10.89
N/A
0.2642
1.45
0.3614
0.4123
2.11
N/A
3.61
0.1553
Kurtosis
8.9
N/A
39.22
43.98
(0.06)
17.44
(0.21)
N/A
1.4
1.2
Potential Upside
14.86
N/A
0.2413
1.45
0.6405
0.5728
3.48
N/A
7.81
0.2417
Treynor Ratio
(0.38)
N/A
0.4605
8.99
10.66
0.3122
0.1243
N/A
0.2774
0.4276
Maximum Drawdown
61.8
N/A
2.15
12.34
1.72
3.3
9.0
N/A
16.83
0.8772
Variance
118.64
N/A
0.0698
2.11
0.1306
0.17
4.44
N/A
13.01
0.0241
Market Risk Adjusted Performance
(0.37)
N/A
0.4705
9.0
10.67
0.3222
0.1343
N/A
0.2874
0.4376
Risk Adjusted Performance
(0.02)
N/A
0.1355
0.1605
0.1161
0.1916
0.0766
N/A
0.0682
0.0964
Skewness
0.2862
N/A
5.67
6.01
0.0374
2.97
0.25
N/A
0.6803
0.142
Semi Deviation
N/A
N/A
0.0
0.0
0.1667
0.0
1.88
N/A
2.79
0.0
Information Ratio
(0.05)
N/A
(0.14)
0.1416
(0.08)
0.0435
0.0491
N/A
0.0539
(0.40)
Value At Risk
(10.13)
N/A
(0.12)
(0.88)
(0.59)
(0.40)
(3.22)
N/A
(5.71)
(0.20)
Expected Short fall
N/A
N/A
(0.22)
(0.77)
(0.33)
(0.34)
(1.73)
N/A
(3.55)
(0.15)
Downside Deviation
N/A
N/A
0.1044
0.7121
0.347
0.3229
2.04
N/A
3.43
0.1574
Semi Variance
N/A
N/A
(0.05)
(0.05)
0.0278
(0.06)
3.55
N/A
7.76
(0.01)

Mangoceuticals Common Competition Performance Charts

Five steps to successful analysis of Mangoceuticals Common Competition

Mangoceuticals Common's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Mangoceuticals Common in relation to its competition. Mangoceuticals Common's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Mangoceuticals Common in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Mangoceuticals Common's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Mangoceuticals Common, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Mangoceuticals Common position

In addition to having Mangoceuticals Common in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Macroaxis Index Thematic Idea Now

Macroaxis Index
Macroaxis Index Theme
An experimental equal-weighted index theme of selected equities generated based on Macroaxis rating and scoring system. The Macroaxis Index theme has 52 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Macroaxis Index Theme or any other thematic opportunities.
View All  Next Launch

Additional Tools for Mangoceuticals Stock Analysis

When running Mangoceuticals Common's price analysis, check to measure Mangoceuticals Common's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mangoceuticals Common is operating at the current time. Most of Mangoceuticals Common's value examination focuses on studying past and present price action to predict the probability of Mangoceuticals Common's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mangoceuticals Common's price. Additionally, you may evaluate how the addition of Mangoceuticals Common to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY